International Association of Physicians in AIDS Care
To craft and implement global educational and advocacy strategies to improve the quality of care provided to all people living with HIV/AIDS.
IAPAC envisions a world in which people at risk for and those living with HIV/AIDS may access the best prevention, care, and treatment services delivered by clinicians and allied health workers armed with cutting-edge knowledge and expertise.
IAPAC's 25-Year History
The Physicians Association for AIDS Care (PAAC) was the first organization to support US physicians in the mid-1980s as they ministered to people who, given limited treatment options, were quickly dying of AIDS-related complications. PAAC was the precursor to the International Association of Physicians in AIDS Care (IAPAC), which was incorporated on 7 February 1995 to represent HIV-treating physicians and allied healthcare professionals worldwide. Today, IAPAC is known as the International Association of Providers of AIDS Care -- a name change that took place on 1 December 2012 as formal acknowledgement of the contributions made by various cadres of professional and paraprofessional providers of HIV prevention, care, and treatment services.
Throughout its five-year history, PAAC delivered pre-ART era education about nutrition, pain management, opportunistic infections (OIs), and other complications of HIV disease. It also tackled contentious public policy issues. Most notably, PAAC publicly confronted the American Medical Association (AMA) and the American Dental Association (ADA) in 1991 over proposed sanctions against HIV-infected healthcare workers following reports that an HIV-positive Florida dentist had likely transmitted HIV to three of his patients. The US Centers for Disease Control (CDC) ultimately resolved the dispute by issuing less restrictive guidelines.
From this important beginning, PAAC's successor association, IAPAC, has worked over the past 17 years to marshal the coordinated strength of healthcare professionals worldwide to the benefit of people living with and affected by HIV/AIDS. Because its rebirth coincided with the advent of antiretroviral therapy (ART), IAPAC engaged in education activities worldwide to strengthen the health workforce's capacity to deliver HIV care, treatment, and support. And, its advocacy efforts to scale-up access to ART in developing world countries began in the late 1990s - well before even the United Nations called for breaking down access barriers and facilitating universal access to ART.
IAPAC today represents more than 17,000 clinicians and other healthcare professionals in over 100 countries who deliver both prevention and treatment services in multiple disease areas, including HIV, hepatitis, malaria, and tuberculosis. Its educational, research, technical assistance, and advocacy activities are conducted by a professionally diverse staff, and are guided by an international Board of Trustees composed of highly esteemed medical, public health, and advocacy professionals from across five continents.
IAPAC is recognized under the law of the United States of America as a 501(c)(3) not-for-profit organization. Working in partnership with the healthcare professions, business, government, academe, and religious communities, IAPAC accomplishes its mission through a comprehensive program of education, policy and advocacy, direct technical assistance, research, and care provision initiatives spearheaded by its members.
IAPAC's strength is firmly rooted in the belief that the most effective and creative solutions to ongoing issues of access to and provision of HIV prevention, care, and treatment services evolve from within the association's membership. IAPAC provides educational services to its membership on best clinical practices in managing HIV and its associated complications, while it also develops and implements innovative public healthcare policies that reflect its membership's commitment to changing the course of the HIV pandemic.
How to Reach IAPAC
International Association of Providers of AIDS Care
2200 Pennsylvania Ave., NW
4th Floor East
Washington, DC 20037
Latest by International Association of Physicians in AIDS Care
IAPAC Lauds National HIV/AIDS Strategy, Urges Adequate, Unwavering Funding, Accelerated Implementation
The International Association of Physicians in AIDS Care (IAPAC) lauds the Obama Administration for launching a National HIV/AIDS Strategy that, in its strategic framework and if adequately funded, can help achieve significant progress in the US resp...
Eric GoosbyChicago, Ill. -- The following statement was issued by José M. Zuniga, President/CEO of the International Association of Physicians in AIDS Care (IAPAC):
The International Association of Physicians in AIDS Care (IAPAC) enthusiastically su...
Introduction Three Million Years of Life Saved Acute Shortage of New HIV Docs Late Treatment, No Treatment and Adherence Why Prevention Fails in High-Income Countries Why Prevention Fails (or Works) in Low and Middle-Income Countries A ...
Introduction HIV-Associated Lipodystrophy Insulin Resistance Dyslipidemia Hyperlactatemia and Lactic Acidosis Bone Disease References
The use of effective antiretroviral therapy (ART) has resulted in tremendous improvemen...
Patients coinfected with HIV and hepatitis C virus (HCV) are more likely to develop end-stage liver disease (ESLD) compared to patients who are HCV-monoinfected, according to a study presented by French researchers at the XVI International AIDS Confe...
Introduction Acute Toxicities Chronic Toxicities Lipoatrophy Central Fat Accumulation Dyslipidemia Insulin Resistance/Diabetes Mellitus Life-Threatening Toxicities Adherence/Quality of Life Changing ART in Patients With Virologic ...
Tipranavir, a protease inhibitor (PI), was approved by the US Food and Drug Administration (FDA).
The Joint United Nations Programme on AIDS (UNAIDS) issued the report AIDS in Africa: Three Scenarios to 2025, which included three case studies outl...
Crystal Methamphetamine Use and Antiretroviral Drug Resistance: A Pilot Study of Behavioral and Clinical Correlates
The prevalence of recreational crystal methamphetamine use and related emergency room admissions are on the rise across the United States,1,2 accompanied by a curious media sometimes quick to sensationalize the trend, other times to isolate its imp...
For gay men of a certain age -- this reporter's age, for example -- you could not live in New York in the 1970s and consider yourself cool without reading Edmund White's two novels. Nabokov1 raved. Sontag2 cheered. But for us Forgetting Elena and N...
Guidelines for HIV/hepatitis C virus (HCV)-coinfected patients recommend HCV treatment with pegylated interferon-alfa (PEG-IFN) plus ribavirin (RBV). The adverse effects of IFN/RBV, particularly anemia, may be more common among HIV/HCV-coinfected tha...